(Q33282898)

25 July 2017

Longitudinal patterns of weight gain after breast cancer diagnosis: observations beyond the first year (English)

1 reference

25 July 2017

0 references

1 reference

1 reference

1 reference

Grace Makari-Judson

1

1 reference

PubMed ID

17461900

25 July 2017

Christopher H Judson

series ordinal

2

1 reference

PubMed ID

17461900

25 July 2017

Wilson C Mertens

series ordinal

3

1 reference

25 July 2017

1 May 2007

1 reference

25 July 2017

1 reference

25 July 2017

13

1 reference

25 July 2017

3

1 reference

25 July 2017

258-265

1 reference

Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast

25 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Weight gain during adjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Weight gain in women with localized breast cancer--a descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Weight gain with breast cancer adjuvant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Exercise and weight gain in breast cancer patients receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Fatigue, weight gain, lethargy and amenorrhea in breast cancer patients on chemotherapy: is subclinical hypothyroidism the culprit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Weight gain during adjuvant and neoadjuvant chemotherapy for breast cancer: an audit of 100 women receiving FEC or CMF chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Weight gain in women with breast cancer treated with adjuvant cyclophosphomide, methotrexate and 5-fluorouracil. Analysis of resting energy expenditure and body composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Side effects of adjuvant chemotherapy: perceptions of node-negative breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Quality of life among younger women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Weight, weight gain, and survival after breast cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Improving the care of patients with regard to chemotherapy-induced nausea and emesis: the effect of feedback to clinicians on adherence to antiemetic prescribing guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Weekly doxorubicin with or without high-dose medroxyprogesterone acetate in hormone-resistant advanced breast cancer. A randomised study. The Norwegian Breast Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Energy balance in women with breast cancer during adjuvant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast canc

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Physical Activity and Survival After Breast Cancer Diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

Energy Balance in Early Breast Cancer Patients Receiving Adjuvant Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00419.X

10.1111/J.1524-4741.2007.00419.X

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference

PubMed ID

17461900